Scholar Rock
Biotechnology • Cambridge, Massachusetts, United States
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth fa…
Headcount
330
51-200 employees
Hiring
35
Open roles
Revenue Signal
$33.2M
Estimated annual revenue
Last Round
$0
Post-IPO Debt